Dual-tracer PET/CT appears valuable for improving tumor staging in patients with hepatocellular carcinoma being evaluated for treatment, according to a study published April 25 in JHEP Reports.
A group led by researchers at the University of Hong Kong in China found the approach detected 12% more disease in patients undergoing staging than CT or MRI and resulted in a change in treatment in a significant number of cases. The results validate the emerging technique, the group noted.
To read more of this article go to Auntminnie